Skip to main content

Table 1 Patient Characteristics

From: Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer – a phase II study

Total Patients 95 100%
Median Age Years (range) 64 (34–84)  
Sex   
   Female 49 52%
   Male 46 48%
Race   
   African American 21 22%
   Caucasian 74 78%
Primary Disease   
   Colon 82 86%
   Rectal 13 14%
Performance Status   
   0 35 37%
   1 52 55%
   2 8 8%